2.99 See Answer

Question: Millager Company is a U.S.-based


Millager Company is a U.S.-based multinational corporation with the U.S. dollar (USD) as its reporting currency. To prepare consolidated financial statements for 2020, the company must trans- late the accounts of its subsidiary in Mexico, Cadengo S.A. On December 31, 2019, Cadengo’s balance sheet was translated from Mexican pesos (MXN) (its functional currency) into U.S. dollars as prescribed by U.S. GAAP. Equity accounts at that date follow:



Millager Company is a U.S.-based multinational corporation with -1

Early in 2020, Cadengo negotiated a 5,000 Brazilian real (BRL) loan from a bank in Rio de Janeiro and established a sales office in Brazil.
At the end of 2020, Cadengo provided Millager a trial balance that includes all of Cadengo’s Mexican peso–denominated transactions for the year. A separate ledger has been maintained for transactions carried out by the Brazilian sales office that are denominated in BRL. A trial balance for the Brazilian real-denominated transactions follows Cadengo’s MXN trial balance.



Millager Company is a U.S.-based multinational corporation with -2




Millager Company is a U.S.-based multinational corporation with -3

Additional Information
The Mexican peso exchange rate for 1 Brazilian real (MXN/BRL) and the U.S. dollar exchange rate for 1 Mexican peso (USD/MXN) during 2020 follow:



Millager Company is a U.S.-based multinational corporation with -4

a. Using an electronic spreadsheet, prepare the Mexican peso trial balance for Cadengo S.A. for the year ending December 31, 2020. Verify the amount of remeasurement gain/loss derived as a plug figure in the spreadsheet through separate calculation.
b. Using a second electronic worksheet, translate Cadengo S.A.’s Mexican peso trial balance into U.S. dollars to facilitate Millager Company’s preparation of consolidated financial statements. Verify the amount of cumulative translation adjustment derived as a plug figure in the spread- sheet through separate calculation. Note: An additional row must be inserted in the trial balance for the remeasurement gain/loss calculated in part a.

2.99

See Answer